Evidence map›Paper›PMID 39935298›Full record

ArticleJournal of applied clinical medical physics2025

Investigation of factors related to treatment planning of x-ray SBRT and scanning carbon-ion radiation therapy for early-stage lung cancer patients.

Yuya Miyasaka, Sung Hyun Lee, Hikaru Souda, Hongbo Chai, Miyu Ishizawa, Takuya Ono, Takashi Ono, Hiraku Sato, Takeo Iwai

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuya MiyasakaDepartment of Heavy Particle Medical Science, Yamagata University Graduate School of Medical Science, Yamagata, Japan.
Sung Hyun LeeDepartment of Heavy Particle Medical Science, Yamagata University Graduate School of Medical Science, Yamagata, Japan.
Hikaru SoudaDepartment of Heavy Particle Medical Science, Yamagata University Graduate School of Medical Science, Yamagata, Japan.
Hongbo ChaiDepartment of Heavy Particle Medical Science, Yamagata University Graduate School of Medical Science, Yamagata, Japan.
Miyu IshizawaDepartment of Heavy Particle Medical Science, Yamagata University Graduate School of Medical Science, Yamagata, Japan.ORCID https://orcid.org/0000-0002-8981-0565
Takuya OnoDepartment of Heavy Particle Medical Science, Yamagata University Graduate School of Medical Science, Yamagata, Japan.
Takashi OnoDepartment of Radiology, Yamagata University Faculty of Medicine, Yamagata, Japan.ORCID https://orcid.org/0000-0002-9711-1158
Hiraku SatoDepartment of Radiology, Yamagata University Faculty of Medicine, Yamagata, Japan.ORCID https://orcid.org/0000-0002-0210-3439
Takeo IwaiDepartment of Heavy Particle Medical Science, Yamagata University Graduate School of Medical Science, Yamagata, Japan.

Funding

JSPS KAKENHI JP 24K18533
6 · The paper itself

Abstract

This study aimed to compare the treatment plans of x-ray SBRT and scanning carbon ion radiation therapy (CIRT) for localized lung tumors, and to evaluate the dose dependence of tumor size tumor-to-heart distance. For phantom verification, we used a chest phantom with a spherical simulated tumor. Treatment plans for 3-dimensional conformal radiation therapy (3D-CRT), volumetric modulated arc therapy (VMAT), and CIRT were created. GTVs were created in sizes ranging from 0.5 to 5 cm in diameter, and the dependence of the lung dose on GTV diameter was evaluated for each treatment plan. For patient validation, 30 cases of localized lung tumors were analyzed. 3D-CRT, VMAT, and CIRT treatment plans were developed, and DVH parameters were evaluated for each GTV size and GTV-to-heart distance. In both phantom and patient validations, the OAR doses were the lowest for CIRT. The lung dose increased with increasing GTV diameter for all three treatment plans. CIRT had the smallest ratio of lung dose increase to GTV diameter increase among the three treatment plans. Heart dose in CIRT was independent of GTV size and GTV-to-heart distance Conclusions: The results of the present study suggested that the use of scanning CIRT can reduce the OAR dose while guaranteeing the tumor dose compared to x-ray SBRT. In addition, it was suggested that CIRT can treat patients with large GTV sizes while maintaining low lung and heart dose.

Indexed as

Heavy Ion RadiotherapyLung NeoplasmsOrgans at RiskPhantoms, ImagingRadiosurgeryRadiotherapy Planning, Computer-AssistedHumansNeoplasm StagingRadiotherapy, ConformalRadiotherapy DosageRadiotherapy, Intensity-Modulatedcarbon ion radiation therapylung cancerSBRTtreatment planningVMAT

Identifiers

PMID39935298
PMCPMC11969111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.